NOX1 and Parkinson disease: Here, we assessed whether the inhibition of NOX-1,-2 and -4 (Table 1) can be beneficial in reducing cellular oxidative stress and preventing protein aggregation, and further dopaminergic neuronal loss in PD pathology for opening up new avenues of targeted therapies [14,15].